Nanospray drying as a novel technique for the manufacturing of inhalable NSAID powders
- PMID: 25580462
- PMCID: PMC4279258
- DOI: 10.1155/2014/838410
Nanospray drying as a novel technique for the manufacturing of inhalable NSAID powders
Abstract
The aim of this research was to evaluate the potential of the nanospray drier as a novel apparatus for the manufacturing of a dry powder for inhalation containing ketoprofen lysinate, a nonsteroidal anti-inflammatory drug able to control the inflammation in cystic fibrosis patients. We produced several ketoprofen lysinate and leucine powder batches by means of nanospray dryer, studying the influence of process parameters on yield, particle properties (size distribution and morphology), and, mainly, aerodynamic properties of powders. Micronized particles were prepared from different hydroalcoholic solutions (alcohol content from 0 to 30% v/v) using ketoprofen in its lysine salt form and leucine as dispersibility enhancer in different ratios (from 5 to 15% w/w) with a total solid concentration ranging from 1 to 7% w/v. Results indicated that the spray head equipped with a 7 µm nozzle produced powders too big to be inhaled. The reduction of nozzle size from 7 to 4 µm led to smaller particles suitable for inhalation but, at the same time, caused a dramatic increase in process time. The selection of process variables, together with the nozzle pretreatment with a surfactant solution, allowed us to obtain a free flowing powder with satisfying aerosol performance, confirming the usefulness of the nanospray drier in the production of powder for inhalation.
Figures




Similar articles
-
Non-steroidal anti-inflammatory drug for pulmonary administration: design and investigation of ketoprofen lysinate fine dry powders.Int J Pharm. 2013 May 1;448(1):198-204. doi: 10.1016/j.ijpharm.2013.03.030. Epub 2013 Mar 23. Int J Pharm. 2013. PMID: 23528281
-
Dry powder inhalers of gentamicin and leucine: formulation parameters, aerosol performance and in vitro toxicity on CuFi1 cells.Int J Pharm. 2012 Apr 15;426(1-2):100-107. doi: 10.1016/j.ijpharm.2012.01.026. Epub 2012 Jan 23. Int J Pharm. 2012. PMID: 22301426
-
Inhalable co-amorphous budesonide-arginine dry powders prepared by spray drying.Int J Pharm. 2019 Jun 30;565:1-8. doi: 10.1016/j.ijpharm.2019.04.036. Epub 2019 Apr 15. Int J Pharm. 2019. PMID: 30999050
-
Characterization and aerosol dispersion performance of advanced spray-dried chemotherapeutic PEGylated phospholipid particles for dry powder inhalation delivery in lung cancer.Eur J Pharm Sci. 2013 Jul 16;49(4):699-711. doi: 10.1016/j.ejps.2013.05.012. Epub 2013 May 23. Eur J Pharm Sci. 2013. PMID: 23707466 Free PMC article.
-
The role of particle properties in pharmaceutical powder inhalation formulations.J Aerosol Med. 2002 Fall;15(3):325-30. doi: 10.1089/089426802760292672. J Aerosol Med. 2002. PMID: 12396421 Review.
Cited by
-
A Novel Combined Dry Powder Inhaler Comprising Nanosized Ketoprofen-Embedded Mannitol-Coated Microparticles for Pulmonary Inflammations: Development, In Vitro-In Silico Characterization, and Cell Line Evaluation.Pharmaceuticals (Basel). 2024 Jan 7;17(1):75. doi: 10.3390/ph17010075. Pharmaceuticals (Basel). 2024. PMID: 38256908 Free PMC article.
-
Development of an Improved Inhalable Powder Formulation of Pirfenidone by Spray-Drying: In Vitro Characterization and Pharmacokinetic Profiling.Pharm Res. 2016 Jun;33(6):1447-55. doi: 10.1007/s11095-016-1887-3. Epub 2016 Mar 14. Pharm Res. 2016. PMID: 26975360
-
Development and Pharmacokinetics of a Novel Acetylsalicylic Acid Dry Powder for Pulmonary Administration.Pharmaceutics. 2022 Dec 15;14(12):2819. doi: 10.3390/pharmaceutics14122819. Pharmaceutics. 2022. PMID: 36559312 Free PMC article.
References
-
- De Cicco F., Reverchon E., Adami R., Auriemma G., Russo P., Calabrese E. C., Porta A., Aquino R. P., Del Gaudio P. In situ forming antibacterial dextran blend hydrogel for wound dressing: SAA technology vs. spray drying. Carbohydrate Polymers. 2014;101(1):1216–1224. doi: 10.1016/j.carbpol.2013.10.067. - DOI - PubMed
-
- Prota L., Santoro A., Bifulco M., Aquino R. P., Mencherini T., Russo P. Leucine enhances aerosol performance of Naringin dry powder and its activity on cystic fibrosis airway epithelial cells. International Journal of Pharmaceutics. 2011;412(1-2):8–19. doi: 10.1016/j.ijpharm.2011.03.055. - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources